GLP-1 Side Effects: What to Expect and How to Manage Them

GLP-1 receptor agonists are a class of medications used to treat type 2 diabetes and obesity. They work well, but most people experience side effects — especially in the first weeks. The good news: the most common side effects are mild, predictable, and often manageable with small changes in how and what you eat.

This guide explains what side effects to expect from semaglutide, tirzepatide, liraglutide, dulaglutide, and exenatide, how long they typically last, and when something is serious enough to call your clinician. It is educational, not medical advice.

What Are GLP-1 Receptor Agonists?

GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases after you eat. GLP-1 receptor agonists are medications that mimic this hormone. They were first approved to lower blood sugar in type 2 diabetes, and several are now also approved for chronic weight management in people with obesity or overweight with weight-related conditions. [3][4]

Tirzepatide (Mounjaro, Zepbound) is closely related — it activates both the GLP-1 and GIP receptors, so it is sometimes called a 'dual agonist.' [5] For simplicity, this guide groups it with GLP-1 medications because their side-effect profiles overlap.

How GLP-1 Medications Work in the Body

GLP-1 medications do four main things: [3][6]

• Tell the pancreas to release more insulin when blood sugar is high.
• Lower glucagon, a hormone that raises blood sugar.
• Slow how quickly food leaves the stomach (delayed gastric emptying).
• Send fullness signals to the brain, reducing appetite.

These same mechanisms drive most side effects. Slower stomach emptying is why people feel nauseous or full quickly. Stronger brain signals about fullness are why food can lose its appeal. Understanding the 'why' makes side effects easier to manage.

Common Side Effects of GLP-1 Medications

In clinical trials of semaglutide and tirzepatide, gastrointestinal (GI) side effects were the most frequent. Most were mild to moderate and decreased over time. [4][5][7]

Nausea and Vomiting

Nausea is the single most common GLP-1 side effect, reported in roughly 1 in 5 to nearly half of users depending on the medication and dose. [4][5] It is usually worst in the first week after starting or after a dose increase, and tends to fade as your body adjusts. Eating smaller meals, avoiding greasy or very rich foods, and stopping before you feel full all help.

Diarrhea and Constipation

GLP-1s slow the gut, which can cause either constipation or diarrhea depending on the person. [4][7] Constipation is often the longer-lasting of the two. Fiber, fluids, and gentle movement help most people.

Decreased Appetite and Early Fullness

Feeling full quickly is part of how these medications work — but it can be uncomfortable if you push past it. Listen to fullness cues, eat protein first, and aim for several small meals rather than three large ones.

Fatigue and Headache

Some people feel tired or develop mild headaches in the first weeks. Lower calorie intake and mild dehydration are often the cause. Keeping up with water and electrolytes usually helps.

Injection Site Reactions

Most GLP-1s are given as a once-weekly or once-daily injection under the skin (subcutaneous). Mild redness, itching, or a small bump at the injection site is common and usually resolves on its own. [3] Rotating sites (abdomen, thigh, upper arm) reduces irritation.

Less Common Side Effects

Hair Thinning or Loss

Some people on GLP-1s notice hair shedding. In the STEP 1 trial of semaglutide for weight loss, alopecia was reported in about 3% of participants on semaglutide compared with 1% on placebo. [4] This is most likely related to rapid weight loss itself — a known trigger called telogen effluvium — not a direct drug effect. It usually resolves within months once weight stabilizes.

Gallbladder Issues

GLP-1 medications increase the risk of gallstones and gallbladder disease, likely because rapid weight loss itself raises this risk. A meta-analysis found GLP-1 agonists were associated with higher risk of gallbladder and biliary diseases compared with placebo. [8] Severe upper-right abdominal pain, especially after fatty meals, deserves prompt medical attention.

Dehydration

Reduced appetite plus occasional nausea or diarrhea can lead to drinking less than you need. Mild dehydration is uncomfortable; significant dehydration can stress the kidneys. Aim for steady water intake throughout the day.

Heartburn and Reflux

Because food sits in the stomach longer, some people develop reflux or burping. Eating smaller meals and staying upright after eating helps. Persistent reflux should be reviewed by a clinician.

Serious Side Effects to Watch For

These are uncommon, but you should know the warning signs.

Pancreatitis

Acute pancreatitis (inflammation of the pancreas) has been reported in users of GLP-1 medications. The absolute risk is low but real, and the FDA labels for these drugs warn about it. [1][2] Symptoms include severe, persistent upper abdominal pain that may radiate to the back, often with nausea and vomiting. Stop the medication and seek medical care immediately if these occur.

Thyroid C-Cell Tumors (Boxed Warning)

In rodent studies, GLP-1 agonists caused thyroid C-cell tumors. It is unknown whether they cause medullary thyroid carcinoma (MTC) in humans. Because of this, the FDA places a boxed warning on these medications, and they should not be used by anyone with a personal or family history of MTC or MEN 2 syndrome. [1][2]

Hypoglycemia

On their own, GLP-1s rarely cause low blood sugar because they only stimulate insulin release when glucose is elevated. [3] But when combined with insulin or sulfonylureas in type 2 diabetes, the risk goes up significantly. People in this situation may need their other medications adjusted.

Kidney Problems

Severe vomiting or diarrhea can lead to dehydration and, in rare cases, acute kidney injury — especially in people with pre-existing kidney disease. [1] Staying hydrated is the simplest prevention.

Severe Allergic Reactions

Rarely, people develop serious allergic reactions, including anaphylaxis or angioedema. [1] Hives, swelling of the face or throat, or trouble breathing require emergency care.

How Long Do GLP-1 Side Effects Last?

For most people, GI side effects are worst in the first 1–4 weeks of starting and again briefly after each dose increase. In clinical trials, the rate of nausea peaked early and declined over time, even as doses went up gradually. [4][5]

Tips for Managing GLP-1 Side Effects

• Eat smaller, more frequent meals instead of large ones.
• Prioritize lean protein and vegetables; limit fried, greasy, and very sweet foods, which worsen nausea.
• Stop eating when you feel comfortably full — not stuffed.
• Sip water steadily through the day; add electrolytes if you've had vomiting or diarrhea.
• Increase fiber slowly (vegetables, oats, chia, psyllium) for constipation.
• Stay upright for 30–60 minutes after eating if reflux is an issue.
• Rotate injection sites each week.
• Don't 'catch up' on a missed dose without talking to your clinician.
• Ask about a slower dose-escalation schedule if side effects are tough.

When to Contact Your Healthcare Provider

Reach out to your clinician (not the ER) if you have:

• Nausea or vomiting that keeps you from drinking fluids for more than 24 hours.
• Diarrhea or constipation lasting more than a few days.
• Heartburn that doesn't improve with diet changes.
• Persistent fatigue, dizziness, or lightheadedness.
• Worries about hair shedding or skin changes.
• Any symptom that feels new or unusual since your last dose.

Who Should Avoid GLP-1 Medications?

GLP-1 medications are not appropriate for everyone. Based on FDA labeling, they are contraindicated or generally avoided in: [1][2]

• People with a personal or family history of medullary thyroid carcinoma (MTC).
• People with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• People with a prior serious allergic reaction to the medication.
• People with a history of pancreatitis (use with caution).
• People with severe gastroparesis or other serious GI motility disease.
• Pregnancy and breastfeeding: GLP-1s are not recommended; weight loss medications should generally be stopped before conception. [4]
• Children under 12 (semaglutide is approved for ages 12+ for obesity; other agents have different age ranges). [4]

Side Effects by Medication

All GLP-1 medications share the side-effect profile above, but the frequency and intensity vary.

Semaglutide (Ozempic, Wegovy, Rybelsus)

Semaglutide is available as a weekly injection (Ozempic for diabetes, Wegovy for weight management) and a daily oral tablet (Rybelsus). In the STEP 1 trial, the most common side effects were nausea (44%), diarrhea (32%), and vomiting (25%) — most mild to moderate. [4]

Tirzepatide (Mounjaro, Zepbound)

Tirzepatide activates both GIP and GLP-1 receptors. In the SURMOUNT-1 trial, the most common side effects were nausea, diarrhea, and constipation, and these led to discontinuation in fewer than 7% of participants across doses. [5]

Liraglutide (Victoza, Saxenda)

Liraglutide is a daily injection. Because it is dosed daily rather than weekly, some users experience more day-to-day GI symptoms during titration. [9]

Dulaglutide (Trulicity)

Dulaglutide is a once-weekly injection for type 2 diabetes. Side effects are typical of the class, with nausea and diarrhea most common. [10]

Exenatide (Byetta, Bydureon)

Exenatide comes in twice-daily (Byetta) and weekly extended-release (Bydureon) forms. The weekly form is associated with more injection site nodules. [11]

Frequently Asked Questions

Keep reading

GLP-1 Medications

Semaglutide for Weight Loss: How It Works, Results, and Who Qualifies

GLP-1 Medications

Mounjaro Side Effects for Weight Loss: What to Expect and When to Call Your Doctor

Weight Loss

Peptides for Weight Loss: How They Work and What to Know